• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
DUAN Zhouping,LIU Hong,FANG Xin,WEI Xiaohua,ZHOU Jian.Monitoring results of Carbamazepine blood concentration in 118 epilepsy patients and analysis of influencing factors[J].Journal Of Pharmaceutical Research,2020,39(7):427-429[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2425times   Download 2476次 QR Code for this article
Scan with your phone!
118例癫痫患者卡马西平血药浓度监测结果及影响因素分析
段舟萍1,刘红2,方鑫1,魏筱华1,周健1
Font:Larger+|Default|Smaller-
(1.南昌大学第一附属医院,江西 南昌 330006;2.南昌大学研究生院医学部,江西 南昌 330006)
摘要:
目的 探讨癫痫患者卡马西平(CBZ)血药浓度的影响因素,为临床合理使用提供依据。方法 选取118例规律服用卡马西平治疗的癫痫患者作为研究对象,采用高效液相色谱法(HPLC)进行血药浓度监测,分析影响卡马西平血药浓度的因素。结果 75.42%的患者服用卡马西平后血药浓度控制在4~12 μg·mL-1之间;性别因素、年龄因素对卡马西平血药浓度的影响不明显(P>0.05);联合其他抗癫痫药时,无效浓度比例较高,具有统计学差异(P<0.05)。结论 服用卡马西平后,患者卡马西平血药浓度的个体差异大,尤其是合并使用其他癫痫药者。因此应避免联合使用,并积极监测患者药物浓度,实施个体化给药,促进安全合理使用。
关键词:  卡马西平  血药浓度  治疗药物监测  合理使用
DOI:10.13506/j.cnki.jpr.2020.07.014
基金项目:江西省科技厅重大支撑项目(No.20141BBG70018);江西省卫生计生委科技计划(No.20175080)
Monitoring results of Carbamazepine blood concentration in 118 epilepsy patients and analysis of influencing factors
DUAN Zhouping1,LIU Hong2,FANG Xin1,WEI Xiaohua1,ZHOU Jian1
(1.The First Affiliated Hospital of Nanchang University,Nanchang 330006,China;2.Nanchang University,Nanchang 330006,China)
Abstract:
Objective To investigate the factors that were affected concentration of Carbamazepine, provide foundation for clinical rational use.Methods 118 epileptic patients who regularly took CBZ were selected as study subjects.The blood concentration of was detected by high performance liquid chromatography (HPLC), we analyzed the factors which were affecting the blood concentration of carbamazepine.Results The concentration of 75.42% patients was between 4 and 12 μg·mL-1. Gender and age had no significant effect on blood concentration of CBZ (P>0.05). When combined with other antiepileptics, the proportion of ineffective concentration was higher, had significant effect on blood concentration of CBZ (P<0.05).Conclusion There was a great difference in CBZ blood concentration among patients who was taking CBZ, especially among those patients who was using other epilepsy drugs at the same time. Therefore, combination should be avoided, drug concentration should be actively monitored, so as to promote safty use.
Key words:  Carbamazepine  Plasma concentration  Therapeutic drug monitoring(TDM)  Rational use
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.